Ann-charlotte Bjorklund

Huddinge, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Real-world investigation of germline predisposition to myelodysplastic syndromes.

Real-world investigation of germline predisposition to myelodysplastic syndromes.

Journal: Blood advances

Published: February 04, 2026

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.

Journal: Leukemia

Published: April 14, 2025

Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells.

Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells.

Journal: Blood neoplasia

Published: February 12, 2024

Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia.

Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia.

Journal: Scientific reports

Published: December 13, 2023

Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.

Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.

Journal: Cancer research

Published: October 03, 2023

Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts.

Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 20, 2023

Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patients.

Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patients.

Journal: Scientific reports

Published: May 20, 2019

Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment.

Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment.

Journal: Cell death & disease

Published: January 19, 2018

Hallmarks in prostate cancer imaging with Ga68-PSMA-11-PET/CT with reference to detection limits and quantitative properties.

Hallmarks in prostate cancer imaging with Ga68-PSMA-11-PET/CT with reference to detection limits and quantitative properties.

Journal: EJNMMI research

Published: January 17, 2018

RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients.

RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 17, 2017

Sorafenib-induced defective autophagy promotes cell death by necroptosis.

Sorafenib-induced defective autophagy promotes cell death by necroptosis.

Journal: Oncotarget

Published: July 12, 2015

An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.

An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.

Journal: Experimental cell research

Published: May 11, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026